On 30 May 2017
SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2017, to consider and approve the Unaudited Standalone Quarterly results for Quarter ended on March 31, 2017, to consider and approve Standalone and Consolidated Annual Audited Financial Statements for the financial year ended on March 31, 2017, and to consider, recommend dividend, if any for the financial year 2016-2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
